These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 14705939)

  • 1. Using nanoparticle optics assay for direct observation of the function of antimicrobial agents in single live bacterial cells.
    Kyriacou SV; Brownlow WJ; Xu XH
    Biochemistry; 2004 Jan; 43(1):140-7. PubMed ID: 14705939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Real-time probing of membrane transport in living microbial cells using single nanoparticle optics and living cell imaging.
    Xu XH; Brownlow WJ; Kyriacou SV; Wan Q; Viola JJ
    Biochemistry; 2004 Aug; 43(32):10400-13. PubMed ID: 15301539
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Single live cell imaging of chromosomes in chloramphenicol-induced filamentous Pseudomonas aeruginosa.
    Steel C; Wan Q; Xu XH
    Biochemistry; 2004 Jan; 43(1):175-82. PubMed ID: 14705943
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efflux as a mechanism of resistance to antimicrobials in Pseudomonas aeruginosa and related bacteria: unanswered questions.
    Schweizer HP
    Genet Mol Res; 2003 Mar; 2(1):48-62. PubMed ID: 12917802
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Measurement of Pseudomonas aeruginosa multidrug efflux pumps by quantitative real-time polymerase chain reaction.
    Yoneda K; Chikumi H; Murata T; Gotoh N; Yamamoto H; Fujiwara H; Nishino T; Shimizu E
    FEMS Microbiol Lett; 2005 Feb; 243(1):125-31. PubMed ID: 15668010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Assignment of the outer-membrane-subunit-selective domain of the membrane fusion protein in the tripartite xenobiotic efflux pump of Pseudomonas aeruginosa.
    Eda S; Maseda H; Yoshihara E; Nakae T
    FEMS Microbiol Lett; 2006 Jan; 254(1):101-7. PubMed ID: 16451186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Design and study of the efflux function of the EGFP fused MexAB-OprM membrane transporter in Pseudomonas aeruginosa using fluorescence spectroscopy.
    Ding F; Lee KJ; Vahedi-Faridi A; Yoneyama H; Osgood CJ; Xu XH
    Analyst; 2014 Jun; 139(12):3088-96. PubMed ID: 24781334
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resistance against antimicrobial peptides is independent of Escherichia coli AcrAB, Pseudomonas aeruginosa MexAB and Staphylococcus aureus NorA efflux pumps.
    Rieg S; Huth A; Kalbacher H; Kern WV
    Int J Antimicrob Agents; 2009 Feb; 33(2):174-6. PubMed ID: 18945595
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Drug screening model acting on out-membrane protein OprM in pseudomonas aeruginosa efflux pump system].
    Tian R; Yu LY; Xiao CL; Zuo L; Yao TJ; Yang LX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2004 Aug; 26(4):359-63. PubMed ID: 15379256
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Role of the membrane fusion protein in the assembly of resistance-nodulation-cell division multidrug efflux pump in Pseudomonas aeruginosa.
    Mokhonov VV; Mokhonova EI; Akama H; Nakae T
    Biochem Biophys Res Commun; 2004 Sep; 322(2):483-9. PubMed ID: 15325256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efflux pump inhibitors reduce the invasiveness of Pseudomonas aeruginosa.
    Hirakata Y; Kondo A; Hoshino K; Yano H; Arai K; Hirotani A; Kunishima H; Yamamoto N; Hatta M; Kitagawa M; Kohno S; Kaku M
    Int J Antimicrob Agents; 2009 Oct; 34(4):343-6. PubMed ID: 19615866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Function of the MexB efflux-transporter divided into two halves.
    Eda S; Yoneyama H; Nakae T
    Biochemistry; 2003 Jun; 42(23):7238-44. PubMed ID: 12795620
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative in vivo efficacy of meropenem, imipenem, and cefepime against Pseudomonas aeruginosa expressing MexA-MexB-OprM efflux pumps.
    Ong CT; Tessier PR; Li C; Nightingale CH; Nicolau DP
    Diagn Microbiol Infect Dis; 2007 Feb; 57(2):153-61. PubMed ID: 16930925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Overexpression of the multidrug efflux pumps MexCD-OprJ and MexEF-OprN is associated with a reduction of type III secretion in Pseudomonas aeruginosa.
    Linares JF; López JA; Camafeita E; Albar JP; Rojo F; Martínez JL
    J Bacteriol; 2005 Feb; 187(4):1384-91. PubMed ID: 15687203
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of efflux mechanisms on fluoroquinolone resistance in Streptococcus pneumoniae and Pseudomonas aeruginosa.
    Zhanel GG; Hoban DJ; Schurek K; Karlowsky JA
    Int J Antimicrob Agents; 2004 Dec; 24(6):529-35. PubMed ID: 15555873
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MexAB-OprM hyperexpression in NalC-type multidrug-resistant Pseudomonas aeruginosa: identification and characterization of the nalC gene encoding a repressor of PA3720-PA3719.
    Cao L; Srikumar R; Poole K
    Mol Microbiol; 2004 Sep; 53(5):1423-36. PubMed ID: 15387820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multiple genotypic changes in hypersusceptible strains of Pseudomonas aeruginosa isolated from cystic fibrosis patients do not always correlate with the phenotype.
    Wolter DJ; Black JA; Lister PD; Hanson ND
    J Antimicrob Chemother; 2009 Aug; 64(2):294-300. PubMed ID: 19468029
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Secondary-site mutation restores the transport defect caused by the transmembrane domain mutation of the xenobiotic transporter MexB in Pseudomonas aeruginosa.
    Yoneyama H; Maseda H; Yamabayashi Ta TA; Izumi S; Nakae T
    Biochem Biophys Res Commun; 2002 Mar; 292(2):513-8. PubMed ID: 11906191
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of multidrug efflux pumps in the antibiotic resistance of Pseudomonas aeruginosa and other gram-negative bacteria. Insights from the Society of Infectious Diseases Pharmacists.
    Aeschlimann JR
    Pharmacotherapy; 2003 Jul; 23(7):916-24. PubMed ID: 12885104
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.